Related Experiment Videos
Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis
J Lekakis1, M Mavrikakis, M Emmanuel
1Department of Clinical Therapeutics, Alexandra University Hospital, Athens, Greece.
Clinical and Experimental Rheumatology
|April 16, 1998
Summary
Systemic sclerosis patients with long-standing Raynaud's phenomenon may experience cold-induced myocardial ischemia, indicating a heart-specific Raynaud's phenomenon. This occurs even with normal myocardial perfusion during dipyridamole testing.
Area of Science:
- Cardiology
- Rheumatology
- Vascular Medicine
Background:
- Cardiac involvement, including myocardial necrosis, is frequent in systemic sclerosis.
- Vasomotor abnormalities are a potential cause of these cardiac findings.
- Investigating a cardiac manifestation of Raynaud's phenomenon is crucial.
Purpose of the Study:
- To explore the existence of "myocardial Raynaud's phenomenon" in patients with systemic sclerosis.
- To determine if cold exposure triggers myocardial ischemia in these patients.
- To differentiate cardiac vasomotor dysfunction from other causes of cardiac involvement.
Main Methods:
- Studied 25 patients with systemic sclerosis and 14 control patients (lupus or rheumatoid arthritis).
- Utilized cold pressor testing and dipyridamole-thallium-201 scintigraphy to assess myocardial perfusion.
- Correlated findings with the duration of Raynaud's phenomenon.
Main Results:
- Seven out of 25 systemic sclerosis patients with normal dipyridamole tests showed cold-induced transient myocardial ischemia.
- None of the control patients exhibited cold-induced ischemia (p = 0.034).
- Cold-induced ischemia was significantly associated with long-standing Raynaud's phenomenon (> 5 years) (p = 0.019).
Conclusions:
- Systemic sclerosis patients with long-standing Raynaud's phenomenon can develop cold-induced myocardial ischemia.
- This phenomenon occurs despite normal myocardial perfusion during dipyridamole vasodilation.
- This suggests a functional "Raynaud's phenomenon of the heart" in systemic sclerosis.